Next Article in Journal
Synthesis and Characterization of a Binuclear Copper(II)-dipyriamethyrin Complex: [Cu2(dipyriamethyrin)(μ2-1,1-acetato)2]
Next Article in Special Issue
Synthesis and Antimicrobial Activity of Phosphonopeptide Derivatives Incorporating Single and Dual Inhibitors
Previous Article in Journal
Kinetic Isotope Effects and Hydrogen Tunnelling in PCET Oxidations of Ascorbate: New Insights into Aqueous Chemistry?
Previous Article in Special Issue
C-Terminal 1-Aminoethyltetrazole-Containing Oligopeptides as Novel Alanine Racemase Inhibitors
Open AccessArticle

Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance

1
Department of Microbiology, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
2
Department of Applied Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK
3
Sunderland Pharmacy School, University of Sunderland, Sunderland SR1 3SD, UK
*
Author to whom correspondence should be addressed.
Deceased.
Molecules 2020, 25(6), 1445; https://doi.org/10.3390/molecules25061445
Received: 15 February 2020 / Revised: 19 March 2020 / Accepted: 20 March 2020 / Published: 23 March 2020
Given the increase in resistance to antibacterial agents, there is an urgent need for the development of new agents with novel modes of action. As an interim solution, it is also prudent to reinvestigate old or abandoned antibacterial compounds to assess their efficacy in the context of widespread resistance to conventional agents. In the 1970s, much work was performed on the development of peptide mimetics, exemplified by the phosphonopeptide, alafosfalin. We investigated the activity of alafosfalin, di-alanyl fosfalin and β-chloro-L-alanyl-β-chloro-L-alanine against 297 bacterial isolates, including carbapenemase-producing Enterobacterales (CPE) (n = 128), methicillin-resistant Staphylococcus aureus (MRSA) (n = 37) and glycopeptide-resistant enterococci (GRE) (n = 43). The interaction of alafosfalin with meropenem was also examined against 20 isolates of CPE. The MIC50 and MIC90 of alafosfalin for CPE were 1 mg/L and 4 mg/L, respectively and alafosfalin acted synergistically when combined with meropenem against 16 of 20 isolates of CPE. Di-alanyl fosfalin showed potent activity against glycopeptide-resistant isolates of Enterococcus faecalis (MIC90; 0.5 mg/L) and Enterococcus faecium (MIC90; 2 mg/L). Alafosfalin was only moderately active against MRSA (MIC90; 8 mg/L), whereas β-chloro-L-alanyl-β-chloro-L-alanine was slightly more active (MIC90; 4 mg/L). This study shows that phosphonopeptides, including alafosfalin, may have a therapeutic role to play in an era of increasing antibacterial resistance. View Full-Text
Keywords: phosphonopeptides; alafosfalin; carbapenemase; antimicrobial resistance; glycopeptide-resistant enterococci; MRSA phosphonopeptides; alafosfalin; carbapenemase; antimicrobial resistance; glycopeptide-resistant enterococci; MRSA
Show Figures

Figure 1

MDPI and ACS Style

Marrs, E.C.; Varadi, L.; Bedernjak, A.F.; Day, K.M.; Gray, M.; Jones, A.L.; Cummings, S.P.; Anderson, R.J.; Perry, J.D. Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance. Molecules 2020, 25, 1445.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop